Company Profile
Updated: 30-NOV-09Sanofi-Aventis de Mexico S.A. de C.V.
Non-Quoted Public Company
Universidad 1738, Col. Villa Coyoacan, Mexico, 04000, Mexico
()52 55 5484 4400, 52 55 5659 3891 fax, http://www.sanofi-aventis.com.mx
Primary SIC: In Vitro & In Vivo Diagnostic Agents, Primary NAICS: In-Vitro Diagnostic Substance Manufacturing
Description: Manufacturing: Manufacture of diagnostics, pharmaceuticals and cosmetics; importer and exporter: the company specialises in medicines for diabetes, oncology, thrombosis, pain and vaccines. It also has a generics division.
View this company profile - Now for a Limited Time, try Goliath Company Profiles
Free for 3 Days!
2009 BioMedTracker Outlook Report - Insight Into the Developmental Drugs and Catalysts that Could Impact the Biotech Market in 2009.
M2 Presswire; 8/6/2009; 1325 words; ...at Victoza's advisory committee...Hepatitis C (HCV) Major...Europe, and Mexico. Several international...Non-Hodgkin's Lymphoma - PROSTATE...IV. HEPATITIS C (HCV) - Telaprevir...Viramidine - Albuferon V. DEVELOPING...Alkermes - Sanofi-Aventis - MannKind...
Research and Markets: View the Worldwide Market for Vitamins inside the US Today.(Industry overview)
Business Wire; 6/14/2006; 1703 words; ...Complex, and Vitamin C. The specific end-use...Pharmavite, Inc, and Sanofi-Aventis. Contents are as follows...Sanayi Ve Ticaret A.S. (Turkey) - ABIC Ltd...Montenegro) - Altana Pharma S.A. DE C.V. (Mexico) - Altayvitaminy (Russia...
Debiopharm S.A. and Rowfarma S. de R.L. de C.V. Enter Into an Exclusive Licensing Agreement in Mexico for Two Approved Urology and Endometriosis Products - Decapeptyl(R) Depot and Decapeptyl(R) LA.
PR Newswire; 12/20/2004; 1366 words; ...Debiopharm S.A., the independent...agreement with Rowfarma S. de R.L. de C.V., a subsidiary...LA 11.25mg in Mexico. Under the terms...Eloxatin(R), one of Sanofi-Aventis' leading marketed...business, Rowfarma's mission is to provide...
Conflicting Signals For M&A's Direction.
Investment Dealers' Digest; 10/18/2004; 1211 words; ...when deals like the $4 billion bid by Mexico's Cemex S.A. de C.V. to buy Britain's RMC Group gave volume a much-needed boost...largest being the $65 billion acquisition of Aventis SA by Sanofi-Synthelabo SA. Given the choppiness of...
Why Purchase This Company Profile?
- Sales prospecting
- Competitive analysis
- Vendor & supplier evaluation
- Customer evaluation and analysis
- Strategic planning